Achieve Life Sciences Inc (ACHV)

Currency in USD
2.500
-0.140(-5.30%)
Closed·
After Hours
2.530+0.030(+1.20%)
·
ACHV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ACHV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4812.618
52 wk Range
1.8405.310
Key Statistics
Prev. Close
2.64
Open
2.59
Day's Range
2.481-2.618
52 wk Range
1.84-5.31
Volume
915.16K
Average Volume (3m)
910.65K
1-Year Change
-41.59%
Book Value / Share
0.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACHV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.000
Upside
+540.00%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Achieve Life Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Achieve Life Sciences Inc Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Achieve Life Sciences Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of -0.37 matches forecasts; stock down 0.38% pre-market
  • NDA submitted for cytisinicline; FDA decision expected by June 2026
  • $55.4M cash on hand; strong liquidity with 3.51 current ratio
  • Commercial launch planned for late 2026; analyst targets $10-$25
  • Partnerships and synthetic cytisinicline development support growth
Last Updated: 07/08/2025, 17:36
Read Full Transcript

Compare ACHV to Peers and Sector

Metrics to compare
ACHV
Peers
Sector
Relationship
P/E Ratio
−2.5x−3.1x−0.5x
PEG Ratio
0.07−0.010.00
Price/Book
3.0x2.2x2.6x
Price / LTM Sales
-9.5x3.3x
Upside (Analyst Target)
-196.4%43.4%
Fair Value Upside
Unlock5.5%7.1%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.000
(+540.00% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.37 / -0.37
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ACHV Income Statement

People Also Watch

18.23
SRPT
+1.50%
2.56
INMB
-8.24%
0.547
WINT
-6.81%
0.380
ADIL
-1.81%
1.9200
DARE
-5.88%

FAQ

What Stock Exchange Does Achieve Life Sciences Trade On?

Achieve Life Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Achieve Life Sciences?

The stock symbol for Achieve Life Sciences is "ACHV."

What Is the Achieve Life Sciences Market Cap?

As of today, Achieve Life Sciences market cap is 124.21M.

What Is Achieve Life Sciences's Earnings Per Share (TTM)?

The Achieve Life Sciences EPS (TTM) is -1.46.

When Is the Next Achieve Life Sciences Earnings Date?

Achieve Life Sciences will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is ACHV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Achieve Life Sciences Stock Split?

Achieve Life Sciences has split 4 times.

How Many Employees Does Achieve Life Sciences Have?

Achieve Life Sciences has 25 employees.

What is the current trading status of Achieve Life Sciences (ACHV)?

As of 10 Aug 2025, Achieve Life Sciences (ACHV) is trading at a price of 2.50, with a previous close of 2.64. The stock has fluctuated within a day range of 2.48 to 2.62, while its 52-week range spans from 1.84 to 5.31.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.